+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Peptoids Market - Global Forecast 2026-2032- Product Image
Peptoids Market - Global Forecast 2026-2032- Product Image
Sale

Peptoids Market - Global Forecast 2026-2032

  • Report

  • 185 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6123686
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Peptoids Market is projected to reach USD 78.16 Million in 2026. It is expected to continue growing at a CAGR of 10.81%, reaching USD 145.45 Million by 2032.

Peptoids: A Versatile Platform for Synthetic Molecular Design

Peptoids are synthetic oligomers related to peptides, distinguished by the placement of side chains on the nitrogen rather than the alpha carbon of the backbone. This architecture can improve resistance to enzymatic degradation and expand the range of chemical functionalities available to researchers. Applications span biomaterials, molecular recognition, chemical biology, diagnostics research, and drug-discovery workflows. Their value proposition is strongest where tunable sequence design, structural control, and stability are important.

Design Flexibility and Stability Are Reshaping Peptoid Research

Peptoid development is moving from proof-of-concept chemistry toward more systematic design and application-led research. Advances in solid-phase synthesis, automated workflows, sequence encoding, and analytical characterization are improving reproducibility and enabling larger libraries. At the same time, researchers are examining peptoids for antimicrobial materials, targeted delivery, surface coatings, sensors, and supramolecular assemblies. Important constraints remain, including synthesis complexity for specialized structures, characterization requirements, biological validation, and the need to demonstrate advantages over peptides, small molecules, and other polymers.

Artificial Intelligence Accelerates Sequence Discovery and Experimental Prioritization

Artificial intelligence can strengthen the peptoid workflow by learning relationships between sequence, conformation, stability, binding, toxicity, and functional performance. Machine-learning models can prioritize candidates from virtual libraries, identify informative experiments, and support iterative design-make-test cycles. Its impact depends on reliable training data, standardized descriptors, transparent validation, and experimental confirmation. Generative approaches should therefore complement-not replace-chemical expertise, laboratory testing, and regulatory assessment, particularly for candidates intended for biomedical use.

Regional Research Ecosystems Shape Peptoid Adoption

North America benefits from strong academic, biotechnology, materials-science, and translational research networks, while Europe combines advanced chemical biology with coordinated research infrastructure and regulatory expertise. Asia-Pacific is supported by expanding capabilities in synthesis, nanotechnology, biotechnology, and high-throughput experimentation. Latin America is developing opportunities through university-led research and applications in health, agriculture, and materials. The Middle East is increasing emphasis on biotechnology, advanced materials, and research capacity, while Africa presents emerging potential linked to infectious-disease research, diagnostics, local manufacturing, and scientific collaboration. Across all regions, access to instrumentation, skilled personnel, funding, and reproducible protocols remains decisive.

Major Economic and Security Groups Influence Collaboration Priorities

ASEAN can support peptoid activity through regional manufacturing, biotechnology, and research linkages, while BRICS offers a broad base for scientific cooperation, materials development, and health-oriented applications. The European Union provides a framework for coordinated research, shared infrastructure, and compliance-oriented development. G7 members contribute substantial capabilities in advanced chemistry, computational research, and translational science. GCC states are positioning biotechnology and advanced materials within broader diversification programs, and NATO-related ecosystems may support work relevant to medical countermeasures, sensing, and protective materials. Collaboration should account for data governance, export controls, intellectual property, and differences in regulatory practice.

Country Capabilities Differ Across Synthesis, Computation, and Translation

Australia has strengths in biomedical research and advanced materials; Brazil combines biodiversity-oriented science with growing biotechnology capacity; Canada contributes expertise in chemistry, nanotechnology, and life sciences. China has extensive research and manufacturing capabilities, while France, Germany, Italy, Spain, and the United Kingdom offer established chemical, pharmaceutical, and academic ecosystems. India is expanding synthetic chemistry, biotechnology, and computational research. Japan and South Korea are strong in precision manufacturing, materials science, and electronics-enabled sensing. Mexico is developing biotechnology and manufacturing linkages. Russia retains capabilities in chemistry and materials research, although collaboration conditions can be affected by geopolitical and institutional constraints. The United States combines deep academic, industrial, computational, and translational resources. In every country, effective progress depends on shared standards and access to specialized analytical infrastructure.

Build an Evidence-Led Peptoid Development and Commercialization Strategy

Industry leaders should first define application-specific performance requirements and compare peptoids against credible alternatives using consistent assays. They should establish modular synthesis and purification workflows, maintain fully characterized sequence libraries, and use design-of-experiments principles to improve learning efficiency. AI programs should be built around curated experimental data, interpretable models, and laboratory validation. Partnerships with universities, contract research organizations, instrument providers, and application specialists can close capability gaps. Finally, leaders should address intellectual property, biocompatibility, environmental fate, quality systems, and regulatory expectations early rather than treating them as late-stage barriers.

Methodology: Triangulate Chemistry, Applications, Geography, and Technology Signals

This executive summary uses a structured qualitative synthesis of established peptoid chemistry, documented research directions, application domains, regional scientific capabilities, and enabling technologies. Findings are organized by landscape shifts, artificial-intelligence use, geography, economic and security groupings, and country-level capacity. Claims are limited to broadly documented technical and institutional characteristics; no market estimates, market shares, forecasts, or company-specific claims are used. Interpretation should be updated as peer-reviewed evidence, standards, regulatory decisions, and application data develop.

Peptoids’ Progress Depends on Reproducibility, Validation, and Application Fit

Peptoids offer a flexible platform for combining sequence programmability with properties that can differ materially from conventional peptides. The most durable opportunities are likely to emerge where their stability, modularity, or functional diversity solves a clearly defined problem. Progress will depend on reproducible synthesis, rigorous biological and materials testing, responsible use of artificial intelligence, and collaboration across regions and disciplines. Leaders that connect molecular design with validated end-use requirements will be better positioned to convert scientific promise into dependable applications.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Peptoids Market, by Type
7.1. Introduction
7.2. Cyclic
7.3. Linear
8. Peptoids Market, by Synthesis Method
8.1. Introduction
8.2. Solid-Phase Synthesis
8.2.1. Boc Chemistry
8.2.2. Fmoc Chemistry
8.3. Solution-Phase Synthesis
8.3.1. Conventional Heating
8.3.2. Microwave-Assisted
9. Peptoids Market, by Application
9.1. Introduction
9.2. Biomedical Research
9.2.1. Biological Assays
9.2.2. Mechanistic Studies
9.3. Diagnostics
9.3.1. Biomarker Detection
9.3.2. Imaging Agents
9.4. Drug Delivery
9.4.1. Controlled Release
9.4.1.1. Hydrogel-Based Carriers
9.4.1.2. Polymer-Based Carriers
9.4.2. Targeted Delivery
9.5. Drug Discovery
9.5.1. High-Throughput Screening
9.5.2. Molecular Modeling
9.6. Tissue Engineering
9.6.1. Cell Adhesion
9.6.2. Scaffold Functionalization
10. Peptoids Market, by End User
10.1. Introduction
10.2. Academic & Research Institutes
10.2.1. Government Laboratories
10.2.2. Universities
10.3. Biotechnology Companies
10.3.1. Diagnostics
10.3.2. Therapeutics
10.4. CROs
10.4.1. Clinical
10.4.2. Preclinical
10.5. Pharmaceutical Companies
10.5.1. Big Pharma
10.5.2. Generic Pharma
11. Peptoids Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Peptoids Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Peptoids Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Abcam plc
15.2. AnaSpec, Inc.
15.3. Apeptide Co., Ltd.
15.4. Bachem Holding AG
15.5. Biomatik Corporation
15.6. Bio-Synthesis, Inc.
15.7. ChemPep Inc.
15.8. ChinaPeptides Co., Ltd.
15.9. CPC Scientific Inc.
15.10. Creative Peptides LLC
15.11. GenScript Biotech Corporation
15.12. GenScript USA Inc.
15.13. GL Biochem Ltd.
15.14. JPT Peptide Technologies GmbH
15.15. Lonza Group AG
15.16. NovoPro Bioscience Co., Ltd.
15.17. Pepscan Presto B.V.
15.18. Peptide 2.0 Inc.
15.19. Peptides International LLC
15.20. Peptones
15.21. Sigma-Aldrich Co. LLC
15.22. SynPeptide Co., Ltd.
15.23. Thermo Fisher Scientific Inc.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Peptoids Market, Years Considered for the Study
FIGURE 2. Global Peptoids Market, Research Design
FIGURE 3. Global Peptoids Market, Research Framework
FIGURE 4. Global Peptoids Market, Data Triangulation
FIGURE 5. Global Peptoids Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Peptoids Market Size, by Type, 2025 vs 2032 (%)
FIGURE 7. Global Peptoids Market Size, by Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Peptoids Market Size, by Synthesis Method, 2025 vs 2032 (%)
FIGURE 9. Global Peptoids Market Size, by Synthesis Method, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Peptoids Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Peptoids Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Peptoids Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Peptoids Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Peptoids Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Peptoids Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Peptoids Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Peptoids Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Peptoids Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Peptoids Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Peptoids Market Segmentation & Coverage
TABLE 2. Global Peptoids Market Size, 2017-2032 (USD Million)
TABLE 3. Global Peptoids Market Size, by Type, 2017-2032 (USD Million)
TABLE 4. Global Cyclic Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Cyclic Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Cyclic Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Linear Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Linear Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Linear Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Peptoids Market Size, by Synthesis Method, 2017-2032 (USD Million)
TABLE 11. Global Solid-Phase Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Solid-Phase Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Solid-Phase Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Boc Chemistry Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Boc Chemistry Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Boc Chemistry Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Fmoc Chemistry Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Fmoc Chemistry Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Fmoc Chemistry Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Solution-Phase Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Solution-Phase Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Solution-Phase Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Conventional Heating Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Conventional Heating Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Conventional Heating Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Microwave-Assisted Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Microwave-Assisted Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Microwave-Assisted Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Peptoids Market Size, by Application, 2017-2032 (USD Million)
TABLE 30. Global Biomedical Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Biomedical Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Biomedical Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Biological Assays Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Biological Assays Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Biological Assays Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Mechanistic Studies Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Mechanistic Studies Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Mechanistic Studies Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Biomarker Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Biomarker Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Biomarker Detection Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Imaging Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Imaging Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Imaging Agents Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Drug Delivery Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Drug Delivery Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Drug Delivery Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Controlled Release Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Controlled Release Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Controlled Release Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Hydrogel-Based Carriers Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Hydrogel-Based Carriers Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Hydrogel-Based Carriers Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Polymer-Based Carriers Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Polymer-Based Carriers Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Polymer-Based Carriers Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Targeted Delivery Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Targeted Delivery Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Targeted Delivery Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Drug Discovery Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Drug Discovery Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Drug Discovery Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global High-Throughput Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global High-Throughput Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global High-Throughput Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Molecular Modeling Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Molecular Modeling Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Molecular Modeling Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Tissue Engineering Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Tissue Engineering Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Tissue Engineering Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Cell Adhesion Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Cell Adhesion Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Cell Adhesion Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Scaffold Functionalization Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Scaffold Functionalization Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Scaffold Functionalization Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Peptoids Market Size, by End User, 2017-2032 (USD Million)
TABLE 82. Global Academic & Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Academic & Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Academic & Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Government Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Government Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Government Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Universities Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Universities Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Universities Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Therapeutics Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Therapeutics Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Therapeutics Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global CROs Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global CROs Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global CROs Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Clinical Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Clinical Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Clinical Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Preclinical Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Preclinical Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Preclinical Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Big Pharma Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global Big Pharma Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global Big Pharma Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Generic Pharma Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Global Generic Pharma Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. Global Generic Pharma Market Size, by Country, 2017-2032 (USD Million)
TABLE 118. Global Peptoids Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Asia-Pacific Peptoids Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Asia-Pacific Peptoids Market Size, by Type, 2017-2032 (USD Million)
TABLE 121. Asia-Pacific Peptoids Market Size, by Synthesis Method, 2017-2032 (USD Million)
TABLE 122. Asia-Pacific Peptoids Market Size, by Solid-Phase Synthesis, 2017-2032 (USD Million)
TABLE 123. Asia-Pacific Peptoids Market Size, by Solution-Phase Synthesis, 2017-2032 (USD Million)
TABLE 124. Asia-Pacific Peptoids Market Size, by Application, 2017-2032 (USD Million)
TABLE 125. Asia-Pacific Peptoids Market Size, by Biomedical Research, 2017-2032 (USD Million)
TABLE 126. Asia-Pacific Peptoids Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 127. Asia-Pacific Peptoids Market Size, by Drug Delivery, 2017-2032 (USD Million)
TABLE 128. Asia-Pacific Peptoids Market Size, by Controlled Release, 2017-2032 (USD Million)
TABLE 129. Asia-Pacific Peptoids Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 130. Asia-Pacific Peptoids Market Size, by Tissue Engineering, 2017-2032 (USD Million)
TABLE 131. Asia-Pacific Peptoids Market Size, by End User, 2017-2032 (USD Million)
TABLE 132. Asia-Pacific Peptoids Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 133. Asia-Pacific Peptoids Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
TABLE 134. Asia-Pacific Peptoids Market Size, by CROs, 2017-2032 (USD Million)
TABLE 135. Asia-Pacific Peptoids Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 136. North America Peptoids Market Size, by Region, 2017-2032 (USD Million)
TABLE 137. North America Peptoids Market Size, by Type, 2017-2032 (USD Million)
TABLE 138. North America Peptoids Market Size, by Synthesis Method, 2017-2032 (USD Million)
TABLE 139. North America Peptoids Market Size, by Solid-Phase Synthesis, 2017-2032 (USD Million)
TABLE 140. North America Peptoids Market Size, by Solution-Phase Synthesis, 2017-2032 (USD Million)
TABLE 141. North America Peptoids Market Size, by Application, 2017-2032 (USD Million)
TABLE 142. North America Peptoids Market Size, by Biomedical Research, 2017-2032 (USD Million)
TABLE 143. North America Peptoids Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 144. North America Peptoids Market Size, by Drug Delivery, 2017-2032 (USD Million)
TABLE 145. North America Peptoids Market Size, by Controlled Release, 2017-2032 (USD Million)
TABLE 146. North America Peptoids Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 147. North America Peptoids Market Size, by Tissue Engineering, 2017-2032 (USD Million)
TABLE 148. North America Peptoids Market Size, by End User, 2017-2032 (USD Million)
TABLE 149. North America Peptoids Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 150. North America Peptoids Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
TABLE 151. North America Peptoids Market Size, by CROs, 2017-2032 (USD Million)
TABLE 152. North America Peptoids Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 153. Latin America Peptoids Market Size, by Region, 2017-2032 (USD Million)
TABLE 154. Latin America Peptoids Market Size, by Type, 2017-2032 (USD Million)
TABLE 155. Latin America Peptoids Market Size, by Synthesis Method, 2017-2032 (USD Million)
TABLE 156. Latin America Peptoids Market Size, by Solid-Phase Synthesis, 2017-2032 (USD Million)
TABLE 157. Latin America Peptoids Market Size, by Solution-Phase Synthesis, 2017-2032 (USD Million)
TABLE 158. Latin America Peptoids Market Size, by Application, 2017-2032 (USD Million)
TABLE 159. Latin America Peptoids Market Size, by Biomedical Research, 2017-2032 (USD Million)
TABLE 160. Latin America Peptoids Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 161. Latin America Peptoids Market Size, by Drug Delivery, 2017-2032 (USD Million)
TABLE 162. Latin America Peptoids Market Size, by Controlled Release, 2017-2032 (USD Million)
TABLE 163. Latin America Peptoids Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 164. Latin America Peptoids Market Size, by Tissue Engineering, 2017-2032 (USD Million)
TABLE 165. Latin America Peptoids Market Size, by End User, 2017-2032 (USD Million)
TABLE 166. Latin America Peptoids Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 167. Latin America Peptoids Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
TABLE 168. Latin America Peptoids Market Size, by CROs, 2017-2032 (USD Million)
TABLE 169. Latin America Peptoids Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 170. Europe Peptoids Market Size, by Region, 2017-2032 (USD Million)
TABLE 171. Europe Peptoids Market Size, by Type, 2017-2032 (USD Million)
TABLE 172. Europe Peptoids Market Size, by Synthesis Method, 2017-2032 (USD Million)
TABLE 173. Europe Peptoids Market Size, by Solid-Phase Synthesis, 2017-2032 (USD Million)
TABLE 174. Europe Peptoids Market Size, by Solution-Phase Synthesis, 2017-2032 (USD Million)
TABLE 175. Europe Peptoids Market Size, by Application, 2017-2032 (USD Million)
TABLE 176. Europe Peptoids Market Size, by Biomedical Research, 2017-2032 (USD Million)
TABLE 177. Europe Peptoids Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 178. Europe Peptoids Market Size, by Drug Delivery, 2017-2032 (USD Million)
TABLE 179. Europe Peptoids Market Size, by Controlled Release, 2017-2032 (USD Million)
TABLE 180. Europe Peptoids Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 181. Europe Peptoids Market Size, by Tissue Engineering, 2017-2032 (USD Million)
TABLE 182. Europe Peptoids Market Size, by End User, 2017-2032 (USD Million)
TABLE 183. Europe Peptoids Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 184. Europe Peptoids Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
TABLE 185. Europe Peptoids Market Size, by CROs, 2017-2032 (USD Million)
TABLE 186. Europe Peptoids Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 187. Middle East Peptoids Market Size, by Region, 2017-2032 (USD Million)
TABLE 188. Middle East Peptoids Market Size, by Type, 2017-2032 (USD Million)
TABLE 189. Middle East Peptoids Market Size, by Synthesis Method, 2017-2032 (USD Million)
TABLE 190. Middle East Peptoids Market Size, by Solid-Phase Synthesis, 2017-2032 (USD Million)
TABLE 191. Middle East Peptoids Market Size, by Solution-Phase Synthesis, 2017-2032 (USD Million)
TABLE 192. Middle East Peptoids Market Size, by Application, 2017-2032 (USD Million)
TABLE 193. Middle East Peptoids Market Size, by Biomedical Research, 2017-2032 (USD Million)
TABLE 194. Middle East Peptoids Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 195. Middle East Peptoids Market Size, by Drug Delivery, 2017-2032 (USD Million)
TABLE 196. Middle East Peptoids Market Size, by Controlled Release, 2017-2032 (USD Million)
TABLE 197. Middle East Peptoids Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 198. Middle East Peptoids Market Size, by Tissue Engineering, 2017-2032 (USD Million)
TABLE 199. Middle East Peptoids Market Size, by End User, 2017-2032 (USD Million)
TABLE 200. Middle East Peptoids Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 201. Middle East Peptoids Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
TABLE 202. Middle East Peptoids Market Size, by CROs, 2017-2032 (USD Million)
TABLE 203. Middle East Peptoids Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 204. Africa Peptoids Market Size, by Region, 2017-2032 (USD Million)
TABLE 205. Africa Peptoids Market Size, by Type, 2017-2032 (USD Million)
TABLE 206. Africa Peptoids Market Size, by Synthesis Method, 2017-2032 (USD Million)
TABLE 207. Africa Peptoids Market Size, by Solid-Phase Synthesis, 2017-2032 (USD Million)
TABLE 208. Africa Peptoids Market Size, by Solution-Phase Synthesis, 2017-2032 (USD Million)
TABLE 209. Africa Peptoids Market Size, by Application, 2017-2032 (USD Million)
TABLE 210. Africa Peptoids Market Size, by Biomedical Research, 2017-2032 (USD Million)
TABLE 211. Africa Peptoids Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 212. Africa Peptoids Market Size, by Drug Delivery, 2017-2032 (USD Million)
TABLE 213. Africa Peptoids Market Size, by Controlled Release, 2017-2032 (USD Million)
TABLE 214. Africa Peptoids Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 215. Africa Peptoids Market Size, by Tissue Engineering, 2017-2032 (USD Million)
TABLE 216. Africa Peptoids Market Size, by End User, 2017-2032 (USD Million)
TABLE 217. Africa Peptoids Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 218. Africa Peptoids Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
TABLE 219. Africa Peptoids Market Size, by CROs, 2017-2032 (USD Million)
TABLE 220. Africa Peptoids Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 221. Global Peptoids Market Size, by Group, 2017-2032 (USD Million)
TABLE 222. ASEAN Peptoids Market Size, by Group, 2017-2032 (USD Million)
TABLE 223. ASEAN Peptoids Market Size, by Type, 2017-2032 (USD Million)
TABLE 224. ASEAN Peptoids Market Size, by Synthesis Method, 2017-2032 (USD Million)
TABLE 225. ASEAN Peptoids Market Size, by Solid-Phase Synthesis, 2017-2032 (USD Million)
TABLE 226. ASEAN Peptoids Market Size, by Solution-Phase Synthesis, 2017-2032 (USD Million)
TABLE 227. ASEAN Peptoids Market Size, by Application, 2017-2032 (USD Million)
TABLE 228. ASEAN Peptoids Market Size, by Biomedical Research, 2017-2032 (USD Million)
TABLE 229. ASEAN Peptoids Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 230. ASEAN Peptoids Market Size, by Drug Delivery, 2017-2032 (USD Million)
TABLE 231. ASEAN Peptoids Market Size, by Controlled Release, 2017-2032 (USD Million)
TABLE 232. ASEAN Peptoids Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 233. ASEAN Peptoids Market Size, by Tissue Engineering, 2017-2032 (USD Million)
TABLE 234. ASEAN Peptoids Market Size, by End User, 2017-2032 (USD Million)
TABLE 235. ASEAN Peptoids Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 236. ASEAN Peptoids Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
TABLE 237. ASEAN Peptoids Market Size, by CROs, 2017-2032 (USD Million)
TABLE 238. ASEAN Peptoids Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 239. GCC Peptoids Market Size, by Group, 2017-2032 (USD Million)
TABLE 240. GCC Peptoids Market Size, by Type, 2017-2032 (USD Million)
TABLE 241. GCC Peptoids Market Size, by Synthesis Method, 2017-2032 (USD Million)
TABLE 242. GCC Peptoids Market Size, by Solid-Phase Synthesis, 2017-2032 (USD Million)
TABLE 243. GCC Peptoids Market Size, by Solution-Phase Synthesis, 2017-2032 (USD Million)
TABLE 244. GCC Peptoids Market Size, by Application, 2017-2032 (USD Million)
TABLE 245. GCC Peptoids Market Size, by Biomedical Research, 2017-2032 (USD Million)
TABLE 246. GCC Peptoids Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 247. GCC Peptoids Market Size, by Drug Delivery, 2017-2032 (USD Million)
TABLE 248. GCC Peptoids Market Size, by Controlled Release, 2017-2032 (USD Million)
TABLE 249. GCC Peptoids Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 250. GCC Peptoids Market Size, by Tissue Engineering, 2017-2032 (USD Million)
TABLE 251. GCC Peptoids Market Size, by End User, 2017-2032 (USD Million)
TABLE 252. GCC Peptoids Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 253. GCC Peptoids Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
TABLE 254. GCC Peptoids Market Size, by CROs, 2017-2032 (USD Million)
TABLE 255. GCC Peptoids Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 256. European Union Peptoids Market Size, by Group, 2017-2032 (USD Million)
TABLE 257. European Union Peptoids Market Size, by Type, 2017-2032 (USD Million)
TABLE 258. European Union Peptoids Market Size, by Synthesis Method, 2017-2032 (USD Million)
TABLE 259. European Union Peptoids Market Size, by Solid-Phase Synthesis, 2017-2032 (USD Million)
TABLE 260. European Union Peptoids Market Size, by Solution-Phase Synthesis, 2017-2032 (USD Million)
TABLE 261. European Union Peptoids Market Size, by Application, 2017-2032 (USD Million)
TABLE 262. European Union Peptoids Market Size, by Biomedical Research, 2017-2032 (USD Million)
TABLE 263. European Union Peptoids Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 264. European Union Peptoids Market Size, by Drug Delivery, 2017-2032 (USD Million)
TABLE 265. European Union Peptoids Market Size, by Controlled Release, 2017-2032 (USD Million)
TABLE 266. European Union Peptoids Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 267. European Union Peptoids Market Size, by Tissue Engineering, 2017-2032 (USD Million)
TABLE 268. European Union Peptoids Market Size, by End User, 2017-2032 (USD Million)
TABLE 269. European Union Peptoids Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 270. European Union Peptoids Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
TABLE 271. European Union Peptoids Market Size, by CROs, 2017-2032 (USD Million)
TABLE 272. European Union Peptoids Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 273. BRICS Peptoids Market Size, by Group, 2017-2032 (USD Million)
TABLE 274. BRICS Peptoids Market Size, by Type, 2017-2032 (USD Million)
TABLE 275. BRICS Peptoids Market Size, by Synthesis Method, 2017-2032 (USD Million)
TABLE 276. BRICS Peptoids Market Size, by Solid-Phase Synthesis, 2017-2032 (USD Million)
TABLE 277. BRICS Peptoids Market Size, by Solution-Phase Synthesis, 2017-2032 (USD Million)
TABLE 278. BRICS Peptoids Market Size, by Application, 2017-2032 (USD Million)
TABLE 279. BRICS Peptoids Market Size, by Biomedical Research, 2017-2032 (USD Million)
TABLE 280. BRICS Peptoids Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 281. BRICS Peptoids Market Size, by Drug Delivery, 2017-2032 (USD Million)
TABLE 282. BRICS Peptoids Market Size, by Controlled Release, 2017-2032 (USD Million)
TABLE 283. BRICS Peptoids Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 284. BRICS Peptoids Market Size, by Tissue Engineering, 2017-2032 (USD Million)
TABLE 285. BRICS Peptoids Market Size, by End User, 2017-2032 (USD Million)
TABLE 286. BRICS Peptoids Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 287. BRICS Peptoids Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
TABLE 288. BRICS Peptoids Market Size, by CROs, 2017-2032 (USD Million)
TABLE 289. BRICS Peptoids Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 290. G7 Peptoids Market Size, by Group, 2017-2032 (USD Million)
TABLE 291. G7 Peptoids Market Size, by Type, 2017-2032 (USD Million)
TABLE 292. G7 Peptoids Market Size, by Synthesis Method, 2017-2032 (USD Million)
TABLE 293. G7 Peptoids Market Size, by Solid-Phase Synthesis, 2017-2032 (USD Million)
TABLE 294. G7 Peptoids Market Size, by Solution-Phase Synthesis, 2017-2032 (USD Million)
TABLE 295. G7 Peptoids Market Size, by Application, 2017-2032 (USD Million)
TABLE 296. G7 Peptoids Market Size, by Biomedical Research, 2017-2032 (USD Million)
TABLE 297. G7 Peptoids Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 298. G7 Peptoids Market Size, by Drug Delivery, 2017-2032 (USD Million)
TABLE 299. G7 Peptoids Market Size, by Controlled Release, 2017-2032 (USD Million)
TABLE 300. G7 Peptoids Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 301. G7 Peptoids Market Size, by Tissue Engineering, 2017-2032 (USD Million)
TABLE 302. G7 Peptoids Market Size, by End User, 2017-2032 (USD Million)
TABLE 303. G7 Peptoids Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 304. G7 Peptoids Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
TABLE 305. G7 Peptoids Market Size, by CROs, 2017-2032 (USD Million)
TABLE 306. G7 Peptoids Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 307. NATO Peptoids Market Size, by Group, 2017-2032 (USD Million)
TABLE 308. NATO Peptoids Market Size, by Type, 2017-2032 (USD Million)
TABLE 309. NATO Peptoids Market Size, by Synthesis Method, 2017-2032 (USD Million)
TABLE 310. NATO Peptoids Market Size, by Solid-Phase Synthesis, 2017-2032 (USD Million)
TABLE 311. NATO Peptoids Market Size, by Solution-Phase Synthesis, 2017-2032 (USD Million)
TABLE 312. NATO Peptoids Market Size, by Application, 2017-2032 (USD Million)
TABLE 313. NATO Peptoids Market Size, by Biomedical Research, 2017-2032 (USD Million)
TABLE 314. NATO Peptoids Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 315. NATO Peptoids Market Size, by Drug Delivery, 2017-2032 (USD Million)
TABLE 316. NATO Peptoids Market Size, by Controlled Release, 2017-2032 (USD Million)
TABLE 317. NATO Peptoids Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 318. NATO Peptoids Market Size, by Tissue Engineering, 2017-2032 (USD Million)
TABLE 319. NATO Peptoids Market Size, by End User, 2017-2032 (USD Million)
TABLE 320. NATO Peptoids Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 321. NATO Peptoids Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
TABLE 322. NATO Peptoids Market Size, by CROs, 2017-2032 (USD Million)
TABLE 323. NATO Peptoids Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 324. Global Peptoids Market Size, by Country, 2017-2032 (USD Million)
TABLE 325. United States Peptoids Market Size, 2017-2032 (USD Million)
TABLE 326. United States Peptoids Market Size, by Type, 2017-2032 (USD Million)
TABLE 327. United States Peptoids Market Size, by Synthesis Method, 2017-2032 (USD Million)
TABLE 328. United States Peptoids Market Size, by Solid-Phase Synthesis, 2017-2032 (USD Million)
TABLE 329. United States Peptoids Market Size, by Solution-Phase Synthesis, 2017-2032 (USD Million)
TABLE 330. United States Peptoids Market Size, by Application, 2017-2032 (USD Million)
TABLE 331. United States Peptoids Market Size, by Biomedical Research, 2017-2032 (USD Million)
TABLE 332. United States Peptoids Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 333. United States Peptoids Market Size, by Drug Delivery, 2017-2032 (USD Million)
TABLE 334. United States Peptoids Market Size, by Controlled Release, 2017-2032 (USD Million)
TABLE 335. United States Peptoids Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 336. United States Peptoids Market Size, by Tissue Engineering, 2017-2032 (USD Million)
TABLE 337. United States Peptoids Market Size, by End User, 2017-2032 (USD Million)
TABLE 338. United States Peptoids Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 339. United States Peptoids Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
TABLE 340. United States Peptoids Market Size, by CROs, 2017-2032 (USD Million)
TABLE 341. United States Peptoids Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 342. Canada Peptoids Market Size, 2017-2032 (USD Million)
TABLE 343. Canada Peptoids Market Size, by Type, 2017-2032 (USD Million)
TABLE 344. Canada Peptoids Market Size, by Synthesis Method, 2017-2032 (USD Million)
TABLE 345. Canada Peptoids Market Size, by Solid-Phase Synthesis, 2017-2032 (USD Million)
TABLE 346. Canada Peptoids Market Size, by Solution-Phase Synthesis, 2017-2032 (USD Million)
TABLE 347. Canada Peptoids Market Size, by Application, 2017-2032 (USD Million)
TABLE 348. Canada Peptoids Market Size, by Biomedical Research, 2017-2032 (USD Million)
TABLE 349. Canada Peptoids Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 350. Canada Peptoids Market Size, by Drug Delivery, 2017-2032 (USD Million)
TABLE 351. Canada Peptoids Market Size, by Controlled Release, 2017-2032 (USD Million)
TABLE 352. Canada Peptoids Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 353. Canada Peptoids Market Size, by Tissue Engineering, 2017-2032 (USD Million)
TABLE 354. Canada Peptoids Market Size, by End User, 2017-2032 (USD Million)
TABLE 355. Canada Peptoids Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 356. Canada Peptoids Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
TABLE 357. Canada Peptoids Market Size, by CROs, 2017-2032 (USD Million)
TABLE 358. Canada Peptoids Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 359. Mexico Peptoids Market Size, 2017-2032 (USD Million)
TABLE 360. Mexico Peptoids Market Size, by Type, 2017-2032 (USD Million)
TABLE 361. Mexico Peptoids Market Size, by Synthesis Method, 2017-2032 (USD Million)
TABLE 362. Mexico Peptoids Market Size, by Solid-Phase Synthesis, 2017-2032 (USD Million)
TABLE 363. Mexico Peptoids Market Size, by Solution-Phase Synthesis, 2017-2032 (USD Million)
TABLE 364. Mexico Peptoids Market Size, by Application, 2017-2032 (USD Million)
TABLE 365. Mexico Peptoids Market Size, by Biomedical Research, 2017-2032 (USD Million)
TABLE 366. Mexico Peptoids Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 367. Mexico Peptoids Market Size, by Drug Delivery, 2017-2032 (USD Million)
TABLE 368. Mexico Peptoids Market Size, by Controlled Release, 2017-2032 (USD Million)
TABLE 369. Mexico Peptoids Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 370. Mexico Peptoids Market Size, by Tissue Engineering, 2017-2032 (USD Million)
TABLE 371. Mexico Peptoids Market Size, by End User, 2017-2032 (USD Million)
TABLE 372. Mexico Peptoids Market Size, by Academic & Research Institutes, 2017-2032 (USD Million)
TABLE 373. Mexico Peptoids Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
TABLE 374. Mexico Peptoids Market Size, by CROs, 2017-2032 (USD Million)
TABLE 375. Mexico Peptoids Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
TABLE 376. Brazil Peptoids Market Size, 2017-2032 (USD Million)
TABLE 377. Brazil Peptoids Market Size, by Type, 2017-2032 (USD Million)
TABLE 378. Brazil Peptoids Market Size, by Synthesis Method, 2017-2032 (USD Million)
TABLE 379. Brazil Peptoids Market Size, by Solid-Phase Synthesis, 2017-2032 (USD Million)
TABLE 380. Brazil Peptoids Market Size, by Solution-Phase Synthesis, 2017-2032 (USD Million)
TABLE 381. Brazil Peptoids Market Size, by Application, 2017-2032 (USD Million)
TABLE 382. Brazil Peptoids Market Size, by Biomedical Research, 2017-2032 (USD Million)
TABLE 383. Brazil Peptoids Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 384. Brazil Peptoids Market Size, by Drug Delivery, 2017-2032 (USD Million)
TABLE 385. Brazil Peptoids Market Size, by Controlled Release, 2017-2032 (USD Million)
TABLE 386. Brazil Peptoids Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 387. Brazil Peptoids Mar

Companies Mentioned

  • Abcam plc
  • AnaSpec, Inc.
  • Apeptide Co., Ltd.
  • Bachem Holding AG
  • Biomatik Corporation
  • Bio‑Synthesis, Inc.
  • ChemPep Inc.
  • ChinaPeptides Co., Ltd.
  • CPC Scientific Inc.
  • Creative Peptides LLC
  • GenScript Biotech Corporation
  • GenScript USA Inc.
  • GL Biochem Ltd.
  • JPT Peptide Technologies GmbH
  • Lonza Group AG
  • NovoPro Bioscience Co., Ltd.
  • Pepscan Presto B.V.
  • Peptide 2.0 Inc.
  • Peptides International LLC
  • Peptones
  • Sigma-Aldrich Co. LLC
  • SynPeptide Co., Ltd.
  • Thermo Fisher Scientific Inc.

Related Topics

Related Reports

AI-driven Peptide Drug Discovery Platform Market - Global Forecast 2026-2032 - Product Image

AI-driven Peptide Drug Discovery Platform Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Cyclic Peptides Market - Global Forecast 2026-2032 - Product Image

Cyclic Peptides Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Biologics Contract Research Organization Market: Industry Trends and Global Forecasts - Distribution by Type of Biologic, Scale of Operation, Therapeutic Area, and Geography - Product Image

Biologics Contract Research Organization Market: Industry Trends and Global Forecasts - Distribution by Type of Biologic, Scale of Operation, Therapeutic Area, and Geography

  • Report
  • 235 Pages
  • Global
From
Cancer Immunotherapy Drug Discovery Outsourcing - Global Strategic Business Report - Product Image

Cancer Immunotherapy Drug Discovery Outsourcing - Global Strategic Business Report

  • Report
  • 382 Pages
  • Global
From
Drug Discovery Informatics - Global Strategic Business Report - Product Image

Drug Discovery Informatics - Global Strategic Business Report

  • Report
  • 161 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.